Lv21
130 积分 2025-12-16 加入
中国系统性硬化症诊治指南（2026版）
9天前
已完结
DEVELOPMENT AND CHARACTERIZATION OF SL-325, A DR3-TARGETED, ANTAGONISTIC ANTIBODY FOR THE TREATMENT OF IBD
11天前
已关闭
Clinical scoring systems of vitiligo
17天前
已完结
Targeted Degradation of NETs in Lupus with DNASE1L3 Deficiency
20天前
已完结
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases
1个月前
已完结
Mini-PBPK-Based Population Model and Covariate Analysis to Assess the Complex Pharmacokinetics and Pharmacodynamics of RO7449135, an Anti-KLK5/KLK7 Bispecific Antibody in Cynomolgus Monkeys
3个月前
已完结
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis
3个月前
已关闭
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis
3个月前
已完结
Physiological and pathological roles of kallikrein-related peptidases in the epidermis
3个月前
已完结
LB1256 TRIV-509, a dual inhibitor of KLK5 and KLK7, rapidly improves barrier integrity and markers of epidermal differentiation in atopic dermatitis skin explants
3个月前
已完结
皖公网安备34019202002308
